Viewing Study NCT01707368


Ignite Creation Date: 2025-12-24 @ 5:42 PM
Ignite Modification Date: 2025-12-26 @ 7:03 PM
Study NCT ID: NCT01707368
Status: COMPLETED
Last Update Posted: 2018-09-24
First Post: 2012-10-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation
Sponsor: LEO Pharma
Organization:

Study Overview

Official Title: Course of Psoriasis During Long Term Treatment With Calcipotriol Plus Betamethasone in Gel Formulation
Status: COMPLETED
Status Verified Date: 2018-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this observational study is to document the course of disease and relapse management during treatment with Daivobet® Gel under consideration of patient's individual application habits under daily use conditions.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: